Table:
Cell type	pO2modulation	Cell differentiation/ mechanism	Ref.
BM-MSCs	CoCl2	Dopaminergic neuron-like cells/HIF-1α dependent activation of EPO, VEGF, p21	[115]
Rat MSCs	Continuous hypoxia	Increased chondrogenesis/activation of HIF-1α, Akt, p38 MAPK, SOX-9	[119]
Human MSCs	Continuous hypoxia	Inhibited osteogenesis/ HIF-1α dependent inhibition of RUNX2	[121]
MSCs	Continuous hypoxia	Inhibited hypertrophic chondrogenesis	[122]
BM-MSCs	Continuous hypoxia in alginate beads	Increased chondrogenesis/ HIF-1α dependent stimulation of SOX-9	[123]
Human BM-MSCs	Continuous hypoxia in gelatine hydrogel	Increased chondrogenesis	[124]
Human ADSCc	Continuous hypoxia and chondrogenic medium	Increased chondrogenesis	[126]
ADSCc	Continuous 2% oxygen tension	Decreased chondrogenesis and osteogenesis	[127]

Continue parse the picture with markdown style: | Cell type | pO2modulation | Cell differentiation/ mechanism | Ref. | 
 | --- | --- | --- | --- | 
 | BM-MSCs | CoCl2 | Dopaminergic neuron-like cells/HIF-1α dependent activation of EPO, VEGF, p21 | [115] | 
 | Rat MSCs | Continuous hypoxia | Increased chondrogenesis/activation of HIF-1α, Akt, p38 MAPK, SOX-9 | [119] | 
 | Human MSCs | Continuous hypoxia | Inhibited osteogenesis/ HIF-1α dependent inhibition of RUNX2 | [121] | 
 |

MSCs | Continuous hypoxia | Inhibited hypertrophic chondrogenesis | [122] | 
 | BM-MSCs | Continuous hypoxia in alginate beads | Increased chondrogenesis/ HIF-1α dependent stimulation of SOX-9 | [123] | 
 | Human BM-MSCs | Continuous hypoxia in gelatine hydrogel | Increased chondrogenesis | [124] | 
 | Human ADSCc | Continuous hypoxia and chondrogenic medium | Increased chondrogenesis | [126] | 
 | ADSCc | Continuous 2% oxygen tension | Decreased chondrogenesis and osteogenesis | [127] |